Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content

Table 3 The improvement of mSWAT score in early-stage MF before and after treatment

From: Application of urine proteomics in the diagnosis and treatment effectiveness monitoring of early-stage Mycosis Fungoides

Cases

mSWAT score

Before

1 month after

3 months after

6 months after

Case 1

66

44.5(32.58%, SD)

17.9(72.88%, PR)

5.5(91.67%, PR)

Case 4

58.9

46.7(20.71%, SD)

23.6(59.93%, PR)

0(100%, CR)

Case 6

12

8.4(30%, SD)

2.6(78.33%, PR)

0(100%, CR)

Case 8

20.7

19(8.21%, SD)

8.1(60.87%, PR)

0(100%, CR)

Case 11

81.5

66.8(18.04, SD)

31.8(60.98%, PR)

0(100%, CR)

Case 12

72.3

60.5(16.32%, SD)

20.6(71.51%, PR)

0(100%, CR)

Case 13

34

30(11.76%, SD)

11(67.65%, PR)

0(100%, CR)

Case 14

53.9

43(20.22%, SD)

7.8(85.53%, PR)

1(97.48%, PR)

Case 16

77.9

61.5(21.05%, SD)

19.6(74.84%, PR)

0(100%, CR)

Case 17

44.2

34.9(21.04%, SD)

13.7(69%, PR)

0(100%, CR)

Case 18

78.9

65.5(16.98%, SD)

12.9(83.65%, PR)

0(100%, CR)

Case 19

51.1

45.4(11.15%, SD)

8(84.34%, PR)

0(100%, CR)

Case 20

14

8.5(39.29%, SD)

2.8(80%, PR)

0(100%, CR)

M ± SD

51.18 ± 24.71

41.13 ± 20.20

13.88 ± 8.53***

0.50 ± 1.53***, #

  1. P***<0.001 vs. before treatment; P#<0.05 vs. 3 months of treatment. CR, complete remission; PR, partial response; SD, stable disease; PD, progressive disease